Literature DB >> 24977032

Pulmonary alveolar proteinosis.

Adrian Kwok Wai Chan1, Angela Takano1, Ann Ling Hsu1, Su Ying Low1.   

Abstract

We report a 68-year-old female who presented with chronic cough and progressive dyspnoea. Computed tomography of the thorax and subsequent bronchoscopy confirmed the diagnosis of pulmonary alveolar proteinosis (PAP), which was treated with whole lung lavage. This case is reported in view of the low incidence of PAP.

Entities:  

Keywords:  Pulmonary alveolar proteinosis (PAP); rare lung diseases; surfactant

Year:  2014        PMID: 24977032      PMCID: PMC4073400          DOI: 10.3978/j.issn.2072-1439.2014.03.33

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  15 in total

Review 1.  Pulmonary alveolar proteinosis.

Authors:  Bruce C Trapnell; Jeffrey A Whitsett; Koh Nakata
Journal:  N Engl J Med       Date:  2003-12-25       Impact factor: 91.245

Review 2.  The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease.

Authors:  A U Wells
Journal:  Eur Respir Rev       Date:  2010-09

3.  CT features of pulmonary alveolar proteinosis.

Authors:  J M Holbert; P Costello; W Li; R M Hoffman; R M Rogers
Journal:  AJR Am J Roentgenol       Date:  2001-05       Impact factor: 3.959

4.  Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis.

Authors:  M S Kavuru; E J Sullivan; R Piccin; M J Thomassen; J K Stoller
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

5.  Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.

Authors:  Yoshikazu Inoue; Bruce C Trapnell; Ryushi Tazawa; Toru Arai; Toshinori Takada; Nobuyuki Hizawa; Yasunori Kasahara; Koichiro Tatsumi; Masaaki Hojo; Toshio Ichiwata; Naohiko Tanaka; Etsuro Yamaguchi; Ryosuke Eda; Kazunori Oishi; Yoshiko Tsuchihashi; Chinatsu Kaneko; Toshihiro Nukiwa; Mitsunori Sakatani; Jeffrey P Krischer; Koh Nakata
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

6.  Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.

Authors:  G Dranoff; A D Crawford; M Sadelain; B Ream; A Rashid; R T Bronson; G R Dickersin; C J Bachurski; E L Mark; J A Whitsett
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

7.  GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.

Authors:  Kanji Uchida; David C Beck; Takashi Yamamoto; Pierre-Yves Berclaz; Shuichi Abe; Margaret K Staudt; Brenna C Carey; Marie-Dominique Filippi; Susan E Wert; Lee A Denson; Jonathan T Puchalski; Diane M Hauck; Bruce C Trapnell
Journal:  N Engl J Med       Date:  2007-02-08       Impact factor: 91.245

Review 8.  Pulmonary alveolar proteinosis: progress in the first 44 years.

Authors:  John F Seymour; Jeffrey J Presneill
Journal:  Am J Respir Crit Care Med       Date:  2002-07-15       Impact factor: 21.405

9.  Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor.

Authors:  N Tanaka; J Watanabe; T Kitamura; Y Yamada; S Kanegasaki; K Nakata
Journal:  FEBS Lett       Date:  1999-01-15       Impact factor: 4.124

10.  Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

Authors:  T Kitamura; N Tanaka; J Watanabe; S Kanegasaki; Y Yamada; K Nakata
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

View more
  1 in total

1.  Simultaneous presentation of two noninflammatory lung diseases in an HIV-infected patient.

Authors:  Rafael Martínez-Girón; Santiago Martínez-Torre
Journal:  Ann Thorac Med       Date:  2017 Apr-Jun       Impact factor: 2.219

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.